Matthew Ferry
Matthew Ferry | Morrison Foerster Matt Ferry is a partner in the San Diego office and a member of the firm’s Technology Transactions Group, advising innovative and mission-driven life sciences and technology companies. Matt has more than a decade of experience in structuring, drafting, negotiating, and executing strategic transactions where intellectual property (IP), technology, data, and information assets drive the deal. Matt is passionate about and focuses his practice on assisting innovative companies in industries where the betterment of people’s lives and the world is in view, including in the broader life sciences and technology areas, such as: Pharmaceuticals and biotechnology (including small molecule pharmaceuticals, biologics, nanotherapeutics, drug discovery, antibodies, cell and gene therapy, CRISPR and other gene editing technologies, drug delivery, immunology, and oncology); and Medtech and healthtech (including medical devices, digital health, and other forms of software and hardware in diagnostic and therapeutic applications); and Food and agriculture (including in plants and crop sciences, agriculture and farming, alternative proteins, animal and plant production, and food products and consumer goods); and Cleantech (including renewable energy, biofuels, plastic recycling and carbon capture). · Morrison Foerster
About
Matt Ferry is a partner in the San Diego office of Morrison Foerster and a member of the firm's Technology Transactions Group. He advises innovative and mission-driven life sciences and technology companies and has more than a decade of experience in structuring, drafting, negotiating, and executing strategic transactions involving intellectual property, technology, data, and information assets.